Pakistan · Delayed Price · Currency is PKR BF Biosciences Statistics
Total Valuation
BF Biosciences has a market cap or net worth of PKR 11.56 billion. The enterprise value is 12.63 billion.
| Market Cap | 11.56B |
| Enterprise Value | 12.63B |
Important Dates
The next estimated earnings date is Wednesday, February 24, 2027.
| Earnings Date | Feb 24, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
BF Biosciences has 88.33 million shares outstanding. The number of shares has increased by 1.41% in one year.
| Current Share Class | 88.33M |
| Shares Outstanding | 88.33M |
| Shares Change (YoY) | +1.41% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.58% |
| Float | 25.00M |
Valuation Ratios
The trailing PE ratio is 17.60.
| PE Ratio | 17.60 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 67.31 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.21 |
| EV / Sales | 1.29 |
| EV / EBITDA | 9.03 |
| EV / EBIT | 11.31 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.30.
| Current Ratio | 1.81 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.19 |
| Debt / FCF | n/a |
| Interest Coverage | 12.34 |
Financial Efficiency
Return on equity (ROE) is 12.77% and return on invested capital (ROIC) is 10.42%.
| Return on Equity (ROE) | 12.77% |
| Return on Assets (ROA) | 7.58% |
| Return on Invested Capital (ROIC) | 10.42% |
| Return on Capital Employed (ROCE) | 15.78% |
| Weighted Average Cost of Capital (WACC) | 3.58% |
| Revenue Per Employee | 11.52M |
| Profits Per Employee | 771,699 |
| Employee Count | 852 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, BF Biosciences has paid 436.03 million in taxes.
| Income Tax | 436.03M |
| Effective Tax Rate | 39.87% |
Stock Price Statistics
The stock price has decreased by -15.21% in the last 52 weeks. The beta is -0.11, so BF Biosciences's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -15.21% |
| 50-Day Moving Average | 126.14 |
| 200-Day Moving Average | 138.23 |
| Relative Strength Index (RSI) | 59.99 |
| Average Volume (20 Days) | 253,334 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BF Biosciences had revenue of PKR 9.81 billion and earned 657.49 million in profits. Earnings per share was 7.44.
| Revenue | 9.81B |
| Gross Profit | 4.32B |
| Operating Income | 1.12B |
| Pretax Income | 1.09B |
| Net Income | 657.49M |
| EBITDA | 1.40B |
| EBIT | 1.12B |
| Earnings Per Share (EPS) | 7.44 |
Balance Sheet
The company has 589.27 million in cash and 1.66 billion in debt, with a net cash position of -1.07 billion or -12.11 per share.
| Cash & Cash Equivalents | 589.27M |
| Total Debt | 1.66B |
| Net Cash | -1.07B |
| Net Cash Per Share | -12.11 |
| Equity (Book Value) | 5.48B |
| Book Value Per Share | 62.03 |
| Working Capital | 2.10B |
Cash Flow
In the last 12 months, operating cash flow was 171.80 million and capital expenditures -854.54 million, giving a free cash flow of -682.75 million.
| Operating Cash Flow | 171.80M |
| Capital Expenditures | -854.54M |
| Depreciation & Amortization | 281.55M |
| Net Borrowing | -237.09M |
| Free Cash Flow | -682.75M |
| FCF Per Share | -7.73 |
Margins
Gross margin is 44.05%, with operating and profit margins of 11.38% and 6.70%.
| Gross Margin | 44.05% |
| Operating Margin | 11.38% |
| Pretax Margin | 11.14% |
| Profit Margin | 6.70% |
| EBITDA Margin | 14.25% |
| EBIT Margin | 11.38% |
| FCF Margin | n/a |
Dividends & Yields
BF Biosciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.41% |
| Shareholder Yield | -1.41% |
| Earnings Yield | 5.68% |
| FCF Yield | -5.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BF Biosciences has an Altman Z-Score of 3.97 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.97 |
| Piotroski F-Score | 6 |